Unknown

Dataset Information

0

SuPAR Surprises as a Biomarker of Invasive Outcomes in Pleural Infection.

ABSTRACT:

SUBMITTER: Idell S 

PROVIDER: S-EPMC7301739 | biostudies-literature | 2020 Jun

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

suPAR Surprises as a Biomarker of Invasive Outcomes in Pleural Infection.

Idell Steven S   Lee Y C Gary YCG  

American journal of respiratory and critical care medicine 20200601 12

Similar Datasets

Unknown Pleural Fluid suPAR Levels Predict the Need for Invasive Management in Parapneumonic Effusions.
| S-EPMC7301729 | biostudies-literature
Unknown Urinary suPAR: a non-invasive biomarker of infection and tissue inflammation for use in studies of large free-ranging mammals.
| S-EPMC7062102 | biostudies-literature
Unknown Comparison of outcomes of surgical and other invasive treatment modalities for malignant pleural effusion in patients with pleural carcinomatosis.
| S-EPMC10944730 | biostudies-literature
Unknown No Surprises Act independent dispute resolution outcomes for emergency services.
| S-EPMC11523055 | biostudies-literature
Unknown No Surprises Act Independent Dispute Resolution Outcomes for Air Ambulances.
| S-EPMC11877184 | biostudies-literature
Unknown Detection of Inflammatory Biomarker suPAR in COVID-19 Disease With CHORUS TRIO Instrument.
| S-EPMC10687937 | biostudies-literature
Unknown Soluble Urokinase Plasminogen Activator Receptor (suPAR) as a Biomarker of Systemic Chronic Inflammation.
| S-EPMC8674945 | biostudies-literature
Unknown Pleural macrophages translocate to the lung during infection to promote improved influenza outcomes.
| S-EPMC10743374 | biostudies-literature
Unknown A systematic review of comorbidities and outcomes of adult patients with pleural infection.
| S-EPMC6860993 | biostudies-literature
Unknown Multiplex Soluble Biomarker Analysis from Pleural Effusion.
| S-EPMC7464384 | biostudies-literature